Literature DB >> 19174787

Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.

M J L Romberg-Camps1, P C Dagnelie, A D M Kester, M A M Hesselink-van de Kruijs, M Cilissen, L G J B Engels, C Van Deursen, W H A Hameeteman, F L Wolters, M G V M Russel, R W Stockbrügger.   

Abstract

OBJECTIVES: Disease course in inflammatory bowel disease (IBD) is variable and difficult to predict. To optimize prognosis, it is of interest to identify phenotypic characteristics at disease onset and other prognostic factors that predict disease course. The aim of this study was to evaluate such factors in a population-based IBD group.
METHODS: IBD patients diagnosed between 1 January 1991 and 1 January 2003 were included. A follow-up questionnaire was developed and medical records were reviewed. Patients were classified according to phenotype at diagnosis and risk factors were registered. Disease severity, cumulative medication use, and "surgical" and "nonsurgical" recurrence rates were calculated as outcome parameters.
RESULTS: In total, 476 Crohn's disease (CD), 630 ulcerative colitis (UC), and 81 indeterminate colitis (IC) patients were diagnosed. In CD (mean follow-up 7.6 years), 50% had undergone resective surgery. In UC (mean follow-up 7 years), colectomy rate was 8.3%. First year cumulative recurrence rates per 100 patient-years for CD, UC, and IC were 53, 44, and 42%, respectively. In CD, small bowel localization and stricturing disease were negative prognostic factors for surgery, as was young age. Overall recurrence rate was increased by young age and current smoking. In UC, extensive colitis increased surgical risk. In UC, older age at diagnosis initially increased recurrence risk but was subsequently protective.
CONCLUSIONS: This population-based IBD study showed high recurrence rates in the first year. In CD, small bowel localization, stricturing disease, and young age were predictive for disease recurrence. In UC, extensive colitis and older age at diagnosis were negative prognostic predictors.

Entities:  

Mesh:

Year:  2009        PMID: 19174787     DOI: 10.1038/ajg.2008.38

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  82 in total

1.  Predictors of aggressive inflammatory bowel disease.

Authors:  Andres J Yarur; Sebastian G Strobel; Amar R Deshpande; Maria T Abreu
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-10

Review 2.  Management of Crohn's disease in smokers: is an alternative approach necessary?

Authors:  Pilar Nos; Eugeni Domènech
Journal:  World J Gastroenterol       Date:  2011-08-21       Impact factor: 5.742

3.  [New therapeutic approaches to special diseases of the small intestine].

Authors:  M Schumann; K Herrlinger; M Zeitz; E F Stange
Journal:  Internist (Berl)       Date:  2010-06       Impact factor: 0.743

Review 4.  The Role of Early Biologic Therapy in Inflammatory Bowel Disease.

Authors:  Dana Rachel Berg; Jean-Frederic Colombel; Ryan Ungaro
Journal:  Inflamm Bowel Dis       Date:  2019-11-14       Impact factor: 5.325

5.  Predictors of Outcome in Ulcerative Colitis.

Authors:  Matti Waterman; Jo Knight; Amreen Dinani; Wei Xu; Joanne M Stempak; Kenneth Croitoru; Geoffrey C Nguyen; Zane Cohen; Robin S McLeod; Gordon R Greenberg; A Hillary Steinhart; Mark S Silverberg
Journal:  Inflamm Bowel Dis       Date:  2015-09       Impact factor: 5.325

6.  A watchful waiting approach for newly diagnosed Crohn's disease patients with an inflammatory phenotype.

Authors:  Sharif Yassin; Naomi Fliss Isakov; Yulia Ron; Nathaniel Aviv Cohen; Ayal Hirsch; Nitsan Maharshak
Journal:  Int J Colorectal Dis       Date:  2021-01-06       Impact factor: 2.571

7.  Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn's Disease.

Authors:  Kyle Joshua Fortinsky; David Kevans; Judy Qiang; Wei Xu; Felipe Bellolio; Hillary Steinhart; Raquel Milgrom; Gordon Greenberg; Zane Cohen; Helen Macrae; Joanne Stempak; Robin McLeod; Mark S Silverberg
Journal:  Dig Dis Sci       Date:  2016-10-24       Impact factor: 3.199

8.  Proteomic patterns of colonic mucosal tissues delineate Crohn's colitis and ulcerative colitis.

Authors:  Erin H Seeley; Mary K Washington; Richard M Caprioli; Amosy E M'Koma
Journal:  Proteomics Clin Appl       Date:  2013-05-08       Impact factor: 3.494

9.  Relapse Prevention by Plant-Based Diet Incorporated into Induction Therapy for Ulcerative Colitis: A Single-Group Trial.

Authors:  Mitsuro Chiba; Kunio Nakane; Tsuyotoshi Tsuji; Satoko Tsuda; Hajime Ishii; Hideo Ohno; Kenta Watanabe; Yu Obara; Masafumi Komatsu; Takeshi Sugawara
Journal:  Perm J       Date:  2019

Review 10.  The current state of the art for biological therapies and new small molecules in inflammatory bowel disease.

Authors:  Sudarshan Paramsothy; Adam K Rosenstein; Saurabh Mehandru; Jean-Frederic Colombel
Journal:  Mucosal Immunol       Date:  2018-06-15       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.